Transdermal Buprenorphine for the Treatment of Radiation-Induced Mucositis Pain in Head and Neck Cancer Patients: A Pilot Study

Protocol No
IIT-SHREENIVAS-BUPRENORPHINE
Phase
II
Summary

This project is being done to investigate the efficacy of using FDA approved doses of a Buprenorphine patch in combination with oral Tramadol to provide adequate pain control in radiation induced mucositis

Description
Transdermal buprenorphine for the treatment of radiation induced mucositis pain in head & neck cancer patients: A pilot study
Participating Institutions
Drexel Town Center
Froedtert Hospital
Status
OPEN TO ACCRUAL